Statistics

Total Visits

Views
Value of serum epidermal growth factor receptor in the selection of patients with non-small-cell lung cancer to be treated with the tyrosine kinase inhibitor erlotinib83

Select a period of time:

Number of views in the range

Views
Value of serum epidermal growth factor receptor in the selection of patients with non-small-cell lung cancer to be treated with the tyrosine kinase inhibitor erlotinib21

Views

Views
October 20253
November 20250
December 20250
January 20261
February 20262
March 202612
April 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
United Kingdom2
China2
Argentina1
Brazil1
Colombia1
France1
Italy1
 

Top cities views

Views
Los Angeles2
Ashburn1
Bogotá1
Fortaleza1
Grand Bourg1
Newark1
Secaucus1
Simpsonville1